288 related articles for article (PubMed ID: 28643468)
1. Eltrombopag use in a patient with Wiskott-Aldrich syndrome.
Gabelli M; Marzollo A; Notarangelo LD; Basso G; Putti MC
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28643468
[TBL] [Abstract][Full Text] [Related]
2. Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia.
Gerrits AJ; Leven EA; Frelinger AL; Brigstocke SL; Berny-Lang MA; Mitchell WB; Revel-Vilk S; Tamary H; Carmichael SL; Barnard MR; Michelson AD; Bussel JB
Blood; 2015 Sep; 126(11):1367-78. PubMed ID: 26224646
[TBL] [Abstract][Full Text] [Related]
3. Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children.
Ali S; Gassas A; Kirby-Allen M; Krueger J; Ali M; Schechter T
Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653480
[TBL] [Abstract][Full Text] [Related]
4. Eltrombopag Therapy in Children With Rare Disorders Associated With Thrombocytopenia.
Frączkiewicz J; Sęga-Pondel D; Kazanowska B; Ussowicz M
J Pediatr Hematol Oncol; 2020 Mar; 42(2):113-117. PubMed ID: 31205222
[TBL] [Abstract][Full Text] [Related]
5. Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation in children: Single-centre experience.
Yaman Y; Elli M; Şahin Ş; Özdilli K; Bilgen H; Bayram N; Nepesov S; Anak S
Pediatr Transplant; 2021 Aug; 25(5):e13962. PubMed ID: 33452850
[TBL] [Abstract][Full Text] [Related]
6. Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation.
Fu H; Zhang X; Han T; Mo X; Wang Y; Chen H; Han W; Wang J; Wang F; Yan C; Zhang Y; Sun Y; Liu K; Huang X; Xu L
Bone Marrow Transplant; 2019 Aug; 54(8):1310-1318. PubMed ID: 30664724
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.
Tang C; Chen F; Kong D; Ma Q; Dai H; Yin J; Li Z; Chen J; Zhu X; Mao X; Wu D; Tang X
J Hematol Oncol; 2018 Aug; 11(1):103. PubMed ID: 30115080
[TBL] [Abstract][Full Text] [Related]
8. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
Grainger JD; Locatelli F; Chotsampancharoen T; Donyush E; Pongtanakul B; Komvilaisak P; Sosothikul D; Drelichman G; Sirachainan N; Holzhauer S; Lebedev V; Lemons R; Pospisilova D; Ramenghi U; Bussel JB; Bakshi KK; Iyengar M; Chan GW; Chagin KD; Theodore D; Marcello LM; Bailey CK
Lancet; 2015 Oct; 386(10004):1649-58. PubMed ID: 26231455
[TBL] [Abstract][Full Text] [Related]
9. [Eltrombopag for refractory thrombocytopenia in patients with allogeneic hematopoietic stem cell transplantation].
Ma YR; Huang XJ; Mo XD; Han W; Yan CH; Chen Y; Ji Y; Chen YY; Wang Y; Zhang XH; Liu KY; Xu LP
Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1065-1069. PubMed ID: 28088971
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation.
Karataş A; Göker H; Demiroğlu H; Malkan ÜY; Velet M; Çınar OE; Erdoğdu B; Karadeniz M; Sayınalp N; Aksu S; Haznedaroğlu İC; Özcebe Oİ; Büyükaşık Y
Turk J Med Sci; 2022 Apr; 52(2):413-419. PubMed ID: 36161632
[TBL] [Abstract][Full Text] [Related]
11. Successful Use of Eltrombopag in a Child With Hurler Syndrome After Haploidentical Hematopoietic Stem Cell Transplantation.
Naithani R; Sachdev M; Uttam R
J Pediatr Hematol Oncol; 2016 Mar; 38(2):163-4. PubMed ID: 26491856
[No Abstract] [Full Text] [Related]
12. [Wiskott-Aldrich syndrome: recent progress in diagnosis and treatment].
Nonoyama S
Rinsho Ketsueki; 2009 Oct; 50(10):1570-6. PubMed ID: 19915368
[No Abstract] [Full Text] [Related]
13. Use of eltrombopag for the treatment of poor graft function after hematopoietic stem cell transplantation in children.
Uria-Oficialdegui ML; Alonso L; Benitez-Carabante MI; Renedo B; Oliveras M; Diaz-de-Heredia C
Pediatr Transplant; 2021 Jun; 25(4):e14010. PubMed ID: 33742757
[TBL] [Abstract][Full Text] [Related]
14. [Improvement in platelet count and bleeding symptom during treatment with eltrombopag in a patient with X-linked thrombocytopenia].
Moriyama M; Nishikawa T; Nakamura T; Abematsu T; Nakagawa S; Kodama Y; Okamoto Y; Iwamoto J; Kawano Y
Rinsho Ketsueki; 2021; 62(4):257-261. PubMed ID: 33967149
[TBL] [Abstract][Full Text] [Related]
15. Eltrombopag for Post-Transplantation Thrombocytopenia: Results of Phase II Randomized, Double-Blind, Placebo-Controlled Trial.
Ahmed S; Bashir Q; Bassett R; Poon MC; Valdez B; Konoplev S; Alousi AM; Andersson BS; Ciurea S; Hosing C; Jones R; Kebriaei P; Khouri I; Kim S; Nieto Y; Olson A; Oran B; Parmar S; Qazilbash MH; Rezvani K; Shah N; Shpall EJ; Champlin R; Popat U
Transplant Cell Ther; 2021 May; 27(5):430.e1-430.e7. PubMed ID: 33965187
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of severe thrombocytopenia with the use of thrombopoeitin receptor agonist eltrombopag in a patient with chronic myelomonocytic leukemia.
Modi Y; Shaaban H; Gauchan D; Maroules M
J Oncol Pharm Pract; 2015 Feb; 21(1):74-5. PubMed ID: 25063763
[TBL] [Abstract][Full Text] [Related]
17. Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopenia.
Reid R; Bennett JM; Becker M; Chen Y; Milner L; Phillips GL; Liesveld J
Am J Hematol; 2012 Jul; 87(7):743-5. PubMed ID: 22573520
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment of post-allogeneic hematopoietic transplant immune thrombocytopenia with eltrombopag].
Narita Y; Uchiyama T; Mizumoto C; Takeoka T; Tomo K; Tsuji M; Ohno T
Rinsho Ketsueki; 2018; 59(11):2418-2422. PubMed ID: 30531136
[TBL] [Abstract][Full Text] [Related]
19. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag.
Tarantino MD; Fogarty PF; Shah P; Brainsky A
Platelets; 2015; 26(1):93-6. PubMed ID: 24433306
[TBL] [Abstract][Full Text] [Related]
20. Spotlight on eltrombopag in treatment-refractory chronic primary immune thrombocytopenia.
Garnock-Jones KP
BioDrugs; 2011 Dec; 25(6):401-4. PubMed ID: 22050343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]